S 7710 New York Senate · 2017 Regular Session

Relates to dihydropyrimidine dehydrogenase deficiency testing

Summary
Requires dihydropyrimidine dehydrogenase deficiency testing prior to fluoropyrmidine or other antimetabolite treatment; requires policies and contracts of insurance to include coverage for dihydropyrimidine dehydrogenase deficiency testing; provides for dihydropyrimidine dehydrogenase deficiency testing under the medical assistance program.
Bill status passed 3 of 5 stages cleared
Introduction
Feb 2018
Committee Review
Jun 2018
Senate Passage
Jun 2018
Assembly Passage
Governor
Introduced Feb 9, 2018 Last action Jun 19, 2018
Floor votes · Senate Jun 19, 2018

How they voted

62–0
Passed · 1 other
Total votes 63
Jun 19, 2018
D Democratic32
32 Yea
100% Yea
R Republican31
30 Yea 1
96% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
6
Key actions
1
Committee
3
Jun 19, 2018
Assembly · Referred to committee
REFERRED TO HEALTH
Jun 19, 2018
Senate · Passed
PASSED SENATE
Jun 19, 2018
Senate · Referred to committee
REFERRED TO RULES
Feb 9, 2018
Senate · Referred to committee
REFERRED TO HEALTH
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.